Acsl1 Knockout RAW 264.7 Cell Line
Cat.No.:
EDC07675
Species:
Mouse
Cell Name:
RAW 264.7
Gene:
Acsl1
Gene ID:
14081
Size:
1×10⁶cells
Acsl1 Knockout RAW264.7 Cell Line is an exclusive upgraded CRISPR/Cas9 system-mediated gene knockout cell, with the advantages of Optimized Strategy Design, Efficient Cell Transfection, High-Performotion Cas9 Protein and Hassle-Free Cell Selection.
| Cat.No. | EDC07675 |
|---|---|
| Product Name | Acsl1 Knockout RAW264.7 Cell Line |
| Species | Mouse |
| Cell Line | RAW 264.7 |
| Cellosaurus ID | CVCL_0493 |
| Gene ID | |
| Cell Line Synonyms | RAW264, RAW2647, RAW264.7, RAW-264.7, Raw 264.7, Raw264.7 |
| Gene |
Acsl1
|
| Digestion Time | / |
| Associated Diseases | Leukemia |
| Morphology | Adherent |
| Passage Ratio | 1:5 |
| Complete Culture Medium | DMEM+10% FBS |
| Freezing Medium | 70% complete culture medium+20% FBS+10% DMSO;95% complete culture medium+5% DMSO |
* For research use only. Not intended for use in humans or animals, including clinical, therapeutic, or diagnostic purposes.
| Loci | STR Info (Sample Cell) Sample Cell Line: RAW 264.7 | STR Info (Cell bank) Cell Line: RAW 264.7 | ||
| Allele1 | Allele2 | Allele1 | Allele2 | |
| 1-1 | 16 | 15 | 16 | |
| 1-2 | 17 | 17 | ||
| 2-1 | 16 | 16 | ||
| 3-2 | 14 | 14 | ||
| 4-2 | 22.3 | 22.3 | ||
| 5-5 | 14 | 15 | 14 | |
| 6-4 | 17 | 18 | 18 | |
| 6-7 | 12 | 13 | 12 | |
| 7-1 | 25.2 | 25.2 | ||
| 8-1 | 13 | 13 | ||
| 11-2 | 17 | 17 | ||
| 12-1 | 16 | 16 | ||
| 13-1 | 16.2 | 16.2 | ||
| 15-3 | 22.3 | 22.3 | ||
| 17-2 | 14 | 16 | 14 | 16 |
| 18-3 | 18 | 18 | ||
| 19-2 | 14 | 14 | ||
| X-1 | 24 | 24 | ||
* STR authentication data of this cell line matches with that of cell lines sourced from ATCC, DSMZ, JCRB, and RIKEN databases.
Conclusion: The STR identification of this cell is correct.
Conclusion: The STR identification of this cell is correct.
FAQ
Which is better for studying Acsl1 function, Acsl1 Knockout RAW 264.7 Cell Line or Acsl1 overexpression RAW 264.7 Cell Line?
The choice depends on whether you are studying ACSL1 (long-chain fatty acyl-CoA synthetase 1)'s role as the principal long-chain FA-CoA activating enzyme or modeling its functions in macrophage lipid metabolism and inflammation. The Knockout line is the standard tool for asking whether ACSL1 is required for these processes — ACSL1 is the major long-chain (C12-C20) fatty acyl-CoA synthetase activating LCFAs for β-oxidation, complex lipid synthesis, and signaling; ACSL1 has been characterized in macrophage lipid metabolism with reported roles in inflammation, particularly LPS-induced inflammation and lipid loading. Overexpression is useful for studying ACSL1 gain-of-function effects.
For macrophage lipid-immunology research, the EDITGENE Acsl1 Knockout in RAW 264.7 is highly relevant — RAW 264.7 is a murine macrophage line, and ACSL1 has been characterized with macrophage-specific functions in atherosclerosis and inflammation. Other ACSL family members (ACSL3, ACSL4, ACSL5, ACSL6) expression analysis aids interpretation. Rescue with wild-type or catalytically-dead ACSL1 enables structure-function studies. The knockout is valuable for studying macrophage lipid metabolism, atherosclerosis biology, and emerging ACSL family functions in ferroptosis (ACSL4 is the major ferroptosis-promoting ACSL).
What are the application scenarios for this model?
Primary applications:
• Long-chain FA-CoA synthesis: long-chain acyl-CoA pool analysis by LC-MS in Acsl1-null macrophages.
• LPS-induced inflammation: in macrophage activation context, LPS-induced inflammatory cytokine production analysis.
• Atherosclerosis modeling: in heterologous foam cell-relevant contexts, oxLDL handling and lipid loading studies.
• ACSL family dissection: ACSL3, ACSL4, ACSL5, ACSL6 expression analysis to interpret ACSL1-specific functions.
EDITGENE recommends this RAW 264.7 macrophage model for researchers investigating macrophage lipid metabolism and atherosclerosis biology.
Is this Acsl1 Knockout RAW 264.7 Cell Line compatible with overexpression rescue experiments?
Yes. ACSL1 rescue experiments require attention to acyl-CoA synthetase architecture:
• Construct design: use a codon-modified Acsl1 sequence with a small C-terminal tag (FLAG, HA). ACSL1 has FACS (fatty acyl-CoA synthetase) family architecture with ATP-binding and FA-binding regions — preserve all elements.
• Catalytically-dead rescue: ATP-binding region mutations abolish acyl-CoA synthetase activity.
• Functional readout: rescue should restore long-chain acyl-CoA synthesis activity.
RAW 264.7-specific considerations:
• RAW 264.7 is a murine macrophage cell line widely used as a continuous macrophage model for innate immunity and metabolic-immunology research.
• Lentiviral transduction is supported with moderate efficiency.
• Characterize basal macrophage marker expression and stimulus responsiveness (LPS, IFN-γ) before phenotypic assays.
* Research Use Disclaimer: Content is generated from publicly available research data, bioinformatic resources, and computational analyses for research reference only.
Customer Publications
Chronic Kidney Disease Induces Distinct Alterations of Macrophage Lipid Metabolism in a Mouse Model of Atherosclerosis
Journal Pre-proof
download